"乙肝"标签列表

[APASL2011]替诺福韦治疗192周后无耐药性2011-02-25

[APASL2011]Tenofovir no resistance after 192 weeks2011-02-25

[APASL2011]HBsAg:治疗终点、应答预测指标2011-02-25

[APASL2011]HBsAg: Ultimate endpoint and ultimate predictor of response?2011-02-25

[APASL2011]HBV Population patterns2011-02-25

[APASL2011]HBV感染群体模式2011-02-25

[APASL2011]HBsAg在核苷（酸）类似物对比免疫调节剂治疗中的预测价值2011-02-24

[APASL2011]Predictive values of HBsAg in NUCs vs. immunomodulatory treatment2011-02-24

[APASL2011]替诺福韦治疗慢性HBV单独感染患者随访192周无耐药发生2011-02-24

[APASL2011]我们需要更具有全球适用性的HBV治疗策略2011-02-23

[APASL2011]We Need More Globally Cohesive HBV Treatment Management Strategies2011-02-23

[APASL2011]Emerging trends in the Management of Viral Hepatitis2011-02-23

[APASL2011]Management of Hepatitis B from Asia-Pacific and Western Region Perspective : We Are Seeking Common Ground2011-02-23

[APASL2011]Hot Topics of HBsAg Titer in the Asia-Pacific and Europe - ’An Old Test Revisit’2011-02-23

[APASL2011]Immunomodulatory Action of Interferons and Nucleoside/nucleotide Analogues: They Are Different2011-02-23

[APASL2011]Enlightening the Future: Coming Era of Individualized Treatment of Chronic Hepatitis B2011-02-23

[APASL2011]开启慢性乙肝个体化治疗的新纪元2011-02-23

[APASL2011]HCC Risk Prediction Scoring System Needs Further Validation2011-02-23

[APASL2011]HCC的风险预测评分系统仍需进一步验证——香港大学袁孟峰教授访谈2011-02-23

[APASL2011]Therapy Strategy for Patients with Hepatitis B Resistance-Interview with Prof. Lampertico2011-02-23